148 related articles for article (PubMed ID: 30701614)
1. HDR interventional radiotherapy (brachytherapy) in the treatment of primary and recurrent head and neck malignancies.
Bussu F; Tagliaferri L; Mattiucci G; Parrilla C; Rizzo D; Gambacorta MA; Lancellotta V; Autorino R; Fonnesu C; Kihlgren C; Galli J; Paludetti G; Kovács G; Valentini V
Head Neck; 2019 Jun; 41(6):1667-1675. PubMed ID: 30701614
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated perioperative HDR brachytherapy for recurrent and/or advanced head and neck metastases.
Teudt IU; Kovàcs G; Ritter M; Melchert C; Soror T; Wollenberg B; Meyer JE
Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2707-15. PubMed ID: 26498949
[TBL] [Abstract][Full Text] [Related]
3. Hypofractionated accelerated CT-guided interstitial ¹⁹²Ir-HDR-Brachytherapy as re-irradiation in inoperable recurrent cervical lymphadenopathy from head and neck cancer.
Tselis N; Ratka M; Vogt HG; Kolotas C; Baghi M; Baltas D; Fountzilas G; Georgoulias V; Ackermann H; Zamboglou N
Radiother Oncol; 2011 Jan; 98(1):57-62. PubMed ID: 21129799
[TBL] [Abstract][Full Text] [Related]
4. Interventional radiotherapy (brachytherapy) for re-irradiation of recurrent head and neck malignancies: oncologic outcomes and morbidity.
Bussu F; Fionda B; Rigante M; Rizzo D; Loperfido A; Gallus R; De Luca LM; Corbisiero MF; Lancellotta V; Tondo A; D'Aviero A; Mattiucci GC; Kovacs G; Galli J; Tagliaferri L
Acta Otorhinolaryngol Ital; 2024 May; 44(Suppl. 1):S28-S36. PubMed ID: 38745514
[TBL] [Abstract][Full Text] [Related]
5. Image-guided interstitial high-dose-rate brachytherapy in the treatment of inoperable recurrent head and neck malignancies: An effective option of reirradiation.
Tselis N; Karagiannis E; Kolotas C; Baghi M; Milickovic N; Zamboglou N
Head Neck; 2017 Apr; 39(4):E61-E68. PubMed ID: 28170118
[TBL] [Abstract][Full Text] [Related]
6. Interstitial HDR brachytherapy for advanced recurrent squamous cell carcinoma of the head and neck.
Wiegand S; Sesterhenn AM; Zimmermann AP; Strassmann G; Wilhelm T; Werner JA
Anticancer Res; 2013 Jan; 33(1):249-52. PubMed ID: 23267152
[TBL] [Abstract][Full Text] [Related]
7. Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer.
Pellizzon AC; dos Santos Novaes PE; Conte Maia MA; Ferrigno R; Fogarolli R; Salvajoli JV; Kowalski LP
Head Neck; 2005 Dec; 27(12):1035-41. PubMed ID: 16114005
[TBL] [Abstract][Full Text] [Related]
8. Salvage high-dose-rate (HDR) brachytherapy for recurrent head-and-neck cancer.
Hepel JT; Syed AM; Puthawala A; Sharma A; Frankel P
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1444-50. PubMed ID: 16029806
[TBL] [Abstract][Full Text] [Related]
9. Determinants of complications and outcome in high-risk squamous cell head-and-neck cancer treated with perioperative high-dose rate brachytherapy (PHDRB).
Martínez-Monge R; Pagola Divassón M; Cambeiro M; Gaztañaga M; Moreno M; Arbea L; Montesdeoca N; Alcalde J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e245-54. PubMed ID: 21620582
[TBL] [Abstract][Full Text] [Related]
10. Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.
Emami B; Scott C; Perez CA; Asbell S; Swift P; Grigsby P; Montesano A; Rubin P; Curran W; Delrowe J; Arastu H; Fu K; Moros E
Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1097-104. PubMed ID: 8600093
[TBL] [Abstract][Full Text] [Related]
11. Interstitial low-dose-rate brachytherapy as a salvage treatment for recurrent head-and-neck cancers: long-term results.
Puthawala A; Nisar Syed AM; Gamie S; Chen YJ; Londrc A; Nixon V
Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):354-62. PubMed ID: 11567809
[TBL] [Abstract][Full Text] [Related]
12. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
[TBL] [Abstract][Full Text] [Related]
13. Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies.
Tselis N; Ferentinos K; Kolotas C; Schirren J; Baltas D; Antonakakis A; Ackermann H; Zamboglou N
J Thorac Oncol; 2011 Mar; 6(3):545-52. PubMed ID: 21258257
[TBL] [Abstract][Full Text] [Related]
14. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies.
Grimard L; Esche B; Lamothe A; Cygler J; Spaans J
Head Neck; 2006 Oct; 28(10):888-95. PubMed ID: 16721742
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
[TBL] [Abstract][Full Text] [Related]
16. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for head-and-neck carcinoma.
Nag S; Cano ER; Demanes DJ; Puthawala AA; Vikram B;
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1190-8. PubMed ID: 11483328
[TBL] [Abstract][Full Text] [Related]
17. The potential uses of high-dose-rate brachytherapy in patients with head and neck cancer.
Donath D; Vuong T; Shenouda G; MacDonald B; Tabah R
Eur Arch Otorhinolaryngol; 1995; 252(6):321-4. PubMed ID: 8679148
[TBL] [Abstract][Full Text] [Related]
18. Five-year biochemical recurrence-free and overall survival following high-dose-rate brachytherapy with additional external beam or radical prostatectomy in patients with clinically localized prostate cancer.
Boehm K; Schiffmann J; Tian Z; Lesmana H; Larcher A; Mandel P; Karakiewicz PI; Graefen M; Schwarz R; Krüll A; Tilki D
Urol Oncol; 2016 Mar; 34(3):119.e11-8. PubMed ID: 26602027
[TBL] [Abstract][Full Text] [Related]
19. Interstitial high dose rate brachytherapy in locally progressive or recurrent head and neck cancer.
Krüll A; Friedrich RE; Schwarz R; Thurmann H; Schmelzle R; Alberti W
Anticancer Res; 1999; 19(4A):2695-7. PubMed ID: 10470222
[TBL] [Abstract][Full Text] [Related]
20. High-dose-rate brachytherapy in the treatment of recurrent and residual head and neck cancer.
Glatzel M; Büntzel J; Schröder D; Küttner K; Fröhlich D
Laryngoscope; 2002 Aug; 112(8 Pt 1):1366-71. PubMed ID: 12172246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]